These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia. Barnes TR Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467 [TBL] [Abstract][Full Text] [Related]
6. Akathisia: a distressing complication of neuroleptic treatment. Szabadi E Compr Ther; 1987 Sep; 13(9):3-6. PubMed ID: 2889560 [No Abstract] [Full Text] [Related]
7. The pharmacologic treatment of neuroleptic-induced akathisia. Fleischhacker WW; Roth SD; Kane JM J Clin Psychopharmacol; 1990 Feb; 10(1):12-21. PubMed ID: 1968470 [TBL] [Abstract][Full Text] [Related]
8. Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesia. Wirshing WC; Phelan CK; van Putten T; Marder SR; Engel J J Clin Psychopharmacol; 1990 Oct; 10(5):371-3. PubMed ID: 1979566 [No Abstract] [Full Text] [Related]
9. Movement disorders with neuroleptic drug treatment. Tarsy D Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742 [TBL] [Abstract][Full Text] [Related]
11. Reported association of akathisia with suicide. Sachdev P; Loneragan C J Nerv Ment Dis; 1992 May; 180(5):339. PubMed ID: 1349914 [No Abstract] [Full Text] [Related]
12. The problem of tardive akathisia. Gualtieri CT Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819 [TBL] [Abstract][Full Text] [Related]
14. Drug-induced movement disorders in institutionalised adults with mental retardation: clinical characteristics and risk factors. Sachdev P Aust N Z J Psychiatry; 1992 Jun; 26(2):242-8. PubMed ID: 1353672 [TBL] [Abstract][Full Text] [Related]
15. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321 [TBL] [Abstract][Full Text] [Related]
16. [Chronology of the extrapyramidal effects of neuroleptics, and the nigrostriatal dopaminergic system]. Petit M; Lepine JP; Lesieur P Encephale; 1979; 5(4):297-316. PubMed ID: 42527 [TBL] [Abstract][Full Text] [Related]
17. Fluoxetine and suicidality. Pearlman T J Clin Psychiatry; 1992 Jul; 53(7):256-7. PubMed ID: 1639746 [No Abstract] [Full Text] [Related]